<?xml version="1.0" encoding="UTF-8"?>
<ref id="pds5133-bib-0029">
 <label>29</label>
 <mixed-citation publication-type="journal" id="pds5133-cit-0029">
  <string-name>
   <surname>Goedecke</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Morales</surname>
   <given-names>DR</given-names>
  </string-name>, 
  <string-name>
   <surname>Pacurariu</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Kurz</surname>
   <given-names>X</given-names>
  </string-name>. 
  <article-title>Response to Comment on 'Measuring the impact of medicines regulatory interventions—systematic review and methodological considerations' by Goedecke et al</article-title>. 
  <source xml:lang="en">Br J Clin Pharmacol</source>. 
  <year>2018</year>;
  <volume>84</volume>(
  <issue>9</issue>):
  <fpage>2169</fpage>‐
  <lpage>2170</lpage>.
  <pub-id pub-id-type="pmid">29971816</pub-id>
 </mixed-citation>
</ref>
